Insider · CIK 0001277476

GUYER DAVID R

Reports to the SEC for 4 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001277476

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-12	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,250 sh	$3.50	+$11.4K	6,950
2024-07-12	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,525 sh	$3.26	+$21.3K	13,475
2024-07-12	EYPTEyePoint, Inc.S Sale	Director	SSale	−11.6K sh	$10.06	−$117K	1,850
2024-07-12	EYPTEyePoint, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,250 sh	—	—	3,250
2024-07-12	EYPTEyePoint, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,525 sh	—	—	6,525
2024-06-03	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,525 sh	$3.26	+$21.3K	12,075
2024-06-03	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,250 sh	$3.50	+$11.4K	15,325
2024-06-03	EYPTEyePoint, Inc.S Sale	Director	SSale	−11.6K sh	$10.30	−$120K	3,700
2024-06-03	EYPTEyePoint, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,250 sh	—	—	6,500
2024-06-03	EYPTEyePoint, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,525 sh	—	—	13,050
2024-05-14	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,525 sh	$3.26	+$21.3K	13,925
2024-05-14	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,250 sh	$3.50	+$11.4K	17,175
2024-05-14	EYPTEyePoint, Inc.S Sale	Director	SSale	−11.6K sh	$12.65	−$147K	5,550
2024-05-14	EYPTEyePoint, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,250 sh	—	—	9,750
2024-05-14	EYPTEyePoint, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,525 sh	—	—	19,575
2024-01-05	EYPTEyePoint, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,014
2023-06-20	EYPTEyePoint, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.1K sh	—	—	26,100
2023-06-20	EYPTEyePoint, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2023-02-09	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	—	—	7,400
2023-02-09	EYPTEyePoint, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2022-02-09	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	—	—	4,400
2022-02-09	EYPTEyePoint, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2022-02-09	EYPTEyePoint, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,000 sh	—	—	3,000
2022-02-09	EYPTEyePoint, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	22,000
2021-06-22	EYPTEyePoint, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,500 sh	—	—	2,500
2021-06-22	EYPTEyePoint, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2021-02-28	EYPTEyePoint, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,900 sh	—	—	1,900
2021-02-28	EYPTEyePoint, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,900 sh	—	—	0
2020-12-18	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+205K sh	—	—	205,150
2020-12-18	IVERIC bio, Inc.Restricted Stock UnitsA Award	Director, Executive Chairman	AAward	+103K sh	—	—	102,630
2020-12-14	IVERIC bio, Inc.S Sale	Director, Executive Chairman	SSale	−9,270 sh	$7.16	−$66.4K	70,113
2020-12-12	IVERIC bio, Inc.M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+17.2K sh	—	—	79,383
2020-12-12	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−17.2K sh	—	—	34,400
2020-12-10	IVERIC bio, Inc.S Sale	Director, Executive Chairman	SSale	−9,602 sh	$6.96	−$66.8K	62,183
2020-12-09	IVERIC bio, Inc.M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+17.8K sh	—	—	71,785
2020-12-09	IVERIC bio, Inc.Restricted Stock UnitsA Award	Director, Executive Chairman	AAward	−17.8K sh	—	—	53,437
2020-02-28	EYPTEyePoint, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19K sh	—	—	19,000
2020-02-28	EYPTEyePoint, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33.5K sh	—	—	33,500
2020-01-06	IVERIC bio, Inc.S Sale	Director, Executive Chairman	SSale	−3,367 sh	$8.07	−$27.2K	53,972
2020-01-04	IVERIC bio, Inc.M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+6,250 sh	—	—	57,339
2020-01-04	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−6,250 sh	—	—	0
2019-12-13	IVERIC bio, Inc.S Sale	Director, Executive Chairman	SSale	−9,275 sh	$6.60	−$61.2K	51,089
2019-12-12	IVERIC bio, Inc.M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+17.2K sh	—	—	60,364
2019-12-12	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−17.2K sh	—	—	51,600
2019-12-09	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+143K sh	—	—	142,500
2019-12-09	IVERIC bio, Inc.Restricted Stock UnitsA Award	Director, Executive Chairman	AAward	+71.3K sh	—	—	71,250
2019-01-25	EYPTEyePoint, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2019-01-07	IVERIC bio, Inc.S Sale	Director, Executive Chairman	SSale	−3,859 sh	$1.30	−$5,016.7	43,164
2019-01-04	IVERIC bio, Inc.M Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	+6,250 sh	—	—	47,023
2019-01-04	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Executive Chairman	MExercise/Conversion	−6,250 sh	—	—	6,250

Recent filings

Accepted (ET)
Jul 164
GUYER DAVID R0001562180-24-005752
SEC(opens sec.gov)
Jun 44
GUYER DAVID R0001562180-24-004638
SEC(opens sec.gov)
May 164
GUYER DAVID R0001562180-24-004106
SEC(opens sec.gov)
Jan 94
GUYER DAVID R0001562180-24-000396
SEC(opens sec.gov)
Jun 224
GUYER DAVID R0001562180-23-005451
SEC(opens sec.gov)
Feb 134
GUYER DAVID R0001562180-23-001338
SEC(opens sec.gov)

Companies

Address

C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 35TH FLOOR

NEW YORK, NY, 10119